Baicalin Attenuates Diabetic Cardiomyopathy In Vivo and In Vitro by Inhibiting Autophagy and Cell Death Through SENP1/SIRT3 Signaling Pathway Activation
Antioxidants & Redox Signaling · 2025
DOI: 10.1089/ars.2023.0457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, 2025. Verfasst von Peipei Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Sirtuin 3, Diabetic Cardiomyopathies, Signal Transduction, Autophagy. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 79 Literaturangaben.
Abstract (Originalsprache)
Aims
Diabetic heart damage can lead to cardiomyocyte death, which endangers human health. Baicalin (BAI) is a bioactive compound that plays an important role in cardiovascular diseases. Sentrin/SUMO-specific protease 1 (SENP1) regulates the de-small ubiquitin-like modifier (deSUMOylation) process of Sirtuin 3 (SIRT3) and plays a crucial role in regulating mitochondrial mass and preventing cell injury. Our hypothesis is that BAI regulates the deSUMOylation level of SIRT3 through SENP1 to enhance mitochondrial quality control and prevent cell death, ultimately improving diabetic cardiomyopathy (DCM).
Results
The protein expression of SENP1 decreased in cardiomyocytes induced by high glucose and in db/db mice. The cardioprotective effects of BAI were eliminated by silencing endogenous SENP1, whereas overexpression of SENP1 showed similar cardioprotective effects to those of BAI. Furthermore, co-immunoprecipitation experiments showed that BAI's cardioprotective effect was due to the inhibition of the SUMOylation modification level of SIRT3 by SENP1. Inhibition of SENP1 expression resulted in an increase in SUMOylation of SIRT3. This led to increased acetylation of mitochondrial protein, accumulation of reactive oxygen species, impaired autophagy, impaired mitochondrial oxidative phosphorylation, and increased cell death. None of these changes could be reversed by BAI.
Conclusion
BAI improves DCM by promoting SIRT3 deSUMOylation through SENP1, restoring mitochondrial stability, and preventing the cell death of cardiomyocytes. Innovation: This study proposes for the first time that SIRT3 SUMOylation modification is involved in the development of DCM and provides in vivo and in vitro data support that BAI inhibits cardiomyocyte ferroptosis and apoptosis in DCM through SENP1. Antioxid. Redox Signal. 42, 53-76.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.
- School of Medicine, Zhejiang University, Hangzhou, China.
- School of Medicine, Shaoxing University, Shaoxing, China.
- Department of Cardiovascular, Lihuili Hospital Affiliated to Ningbo University, Ningbo, China.
- Department of Cardiology, Shaoxing People's Hospital, Shaoxing, China.
ORCID-Profile: Hangyuan Guo, Jufang Chi
Zitieren
APA
Zhang, P., Wu, H., Lou, H., Zhou, J., Hao, J., Lin, H., Hu, S., Zhong, Z., Yang, J., Guo, H., & Chi, J. (2025). Baicalin Attenuates Diabetic Cardiomyopathy In Vivo and In Vitro by Inhibiting Autophagy and Cell Death Through SENP1/SIRT3 Signaling Pathway Activation. Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2023.0457
Vancouver
Zhang P, Wu H, Lou H, Zhou J, Hao J, Lin H, et al. Baicalin Attenuates Diabetic Cardiomyopathy In Vivo and In Vitro by Inhibiting Autophagy and Cell Death Through SENP1/SIRT3 Signaling Pathway Activation. Antioxidants & Redox Signaling. 2025. doi:10.1089/ars.2023.0457
BibTeX
@article{Zhang2025,
author = {Zhang, Peipei and Wu, Haowei and Lou, Haifei and Zhou, Jiedong and Hao, Jinjin and Lin, Hui and Hu, Songqing and Zhong, Zuoquan and Yang, Juntao and Guo, Hangyuan and Chi, Jufang},
title = {Baicalin Attenuates Diabetic Cardiomyopathy In Vivo and In Vitro by Inhibiting Autophagy and Cell Death Through SENP1/SIRT3 Signaling Pathway Activation},
journal = {Antioxidants & Redox Signaling},
year = {2025},
doi = {10.1089/ars.2023.0457}
}
EUVIMED